£110.44

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£110 today · all-time low £108 (Sep 2026) · usually £110

Springer Pharmacogenetics: Cancer Treatment Safety & Efficacy - Springer

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical
Generating forecast…
£112.59 £107.29 £108.44 £109.60 £110.76 £111.92 £113.07 01 August 2026 17 August 2026 03 September 2026 20 September 2026 07 October 2026
View at Amazon ↗

Price data last checked 23 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 68 days • 3 price levels

Days at Price
Current Price
14 days 14 days 40 days 0 10 20 30 40 £108 £110 £113 Days at Price

Price Analysis

Most common price: £113 (40 days, 58.8%)

Price range: £108 - £113

Price levels: 3 different prices over 68 days

Description

Pharmacogenetics: Making cancer treatment safer and more effective is a comprehensive guide from Springer that explores how genetic testing can personalise cancer therapy and improve patient outcomes. This up-to-date resource is designed for oncologists and healthcare professionals involved in cancer treatment. The book establishes foundational knowledge in genetics and pharmacological principles, then progresses through expert contributions covering the latest advances in pharmacogenetic testing for oncology. As chemotherapy remains a cornerstone of cancer care, understanding individual genetic profiles helps clinicians tailor prescriptions to maximise efficacy whilst minimising adverse reactions. This essential reference bridges the gap between genetic science and clinical practice, offering practical insights into reducing treatment toxicity and enhancing therapeutic responses across diverse cancer types. Healthcare professionals seeking to incorporate personalised medicine into their practice will find this Springer publication invaluable for understanding current evidence and implementation strategies.

Key Features

Pharmacogenetics book by Springer covers genetic testing applications in cancer treatment optimisation and patient safety.

Designed for oncologists and cancer care professionals seeking to understand personalised medicine in chemotherapy.

Establishes core background in genetics and pharmacological principles before progressing to advanced clinical applications.

Includes chapters from acknowledged experts in pharmacogenetics and oncology with current field knowledge.

Addresses how genetic profiles help tailor effective prescriptions and reduce serious side effects in cancer patients.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
03 June 2010
Listed Since
09 November 2009

Barcode

No barcode data available

Similar Products You Might Like

Pharmacogenetics: Making cancer treatment safer and more effective
98% match

Pharmacogenetics: Making cancer treatment safer and more effective

Springer

£113.76 25 Aug 2026
Chemistry and Pharmacology of Anticancer Drugs
97% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£205.87 02 Oct 2026
Chemistry and Pharmacology of Anticancer Drugs - CRC Press
97% match

Chemistry and Pharmacology of Anticancer Drugs - CRC Press

CRC Press

£126.97 02 Oct 2026
Pharmacogenetics of Breast Cancer: Towards the Individualization of Therapy: 7 (Translational Medicine)
97% match

Pharmacogenetics of Breast Cancer: Towards the Individualization of Therapy: 7 (Translational Medicine)

CRC Press

£83.81 20 Sep 2026
Phase I Oncology Drug Development
97% match

Phase I Oncology Drug Development

Springer

£99.99 23 Sep 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
97% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£27.79 21 Aug 2026
Cancer Chemotherapy: Basic Science to the Clinic
97% match

Cancer Chemotherapy: Basic Science to the Clinic

Wiley

£50.26 08 Sep 2026
Wiley Anticancer Therapeutics - Oncology Drug Design Book
97% match

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Wiley

£138.97 02 Oct 2026
Side Effects of Medical Cancer Therapy: Prevention and Treatment
97% match

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Springer

£105.51 07 Oct 2026
Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)
96% match

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

Springer

£60.42 02 Oct 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
96% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£88.21 12 Sep 2026
Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer
96% match

Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer

WOLTERS KLUWER HEALTH

£58.10 21 Oct 2026
Development and Approval of Combination Products: A Regulatory Perspective
96% match

Development and Approval of Combination Products: A Regulatory Perspective

Wiley

£73.31 07 Oct 2026
The Oncogenomics Handbook (Cancer Drug Discovery and Development)
96% match

The Oncogenomics Handbook (Cancer Drug Discovery and Development)

Humana

£62.71 08 Oct 2026
Springer Clinical Evaluation of Antitumor Therapy: 46 Book
96% match

Springer Clinical Evaluation of Antitumor Therapy: 46 Book

Springer

£164.00 24 Aug 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
96% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£159.29 30 Sep 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
96% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.67 18 Sep 2026
New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)
96% match

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Springer

£113.76 02 Oct 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
96% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£144.79 19 Aug 2026
Elsevier pH-Interfering Agents in Cancer Therapy - Vol 10
96% match

Elsevier pH-Interfering Agents in Cancer Therapy - Vol 10

Elsevier

£119.96 19 Sep 2026
Combination Cancer Therapy: Modulators and Potentiators Guide
96% match

Combination Cancer Therapy: Modulators and Potentiators Guide

Humana

£42.21 06 Oct 2026
Drug Resistance in Cancer Cells
96% match

Drug Resistance in Cancer Cells

Springer

£111.44 30 Sep 2026
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
96% match

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Humana

£148.21 19 Aug 2026
Biochemical Modulation of Anticancer Agents - 1986 Symposium Proceedings
96% match

Biochemical Modulation of Anticancer Agents - 1986 Symposium Proceedings

Springer

£114.00 09 Oct 2026